Literature DB >> 11374661

p53 and neoplastic progression in Barrett's esophagus.

B J Reid.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11374661     DOI： 10.1111/j.1572-0241.2001.03844.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  13 in total

1.  TP53 gene mutations are rare in nondysplastic Barrett's esophagus.

Authors:  Kamila Novotna; Marie Trkova; Alexandr Pazdro; Milan Smejkal; Alzbeta Soukupova; Daniela Kodetova; Premysl Smejkal; Zdenek Sedlacek
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 2.  Barrett esophagus: histology and pathology for the clinician.

Authors:  Robert D Odze
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

Review 3.  Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma.

Authors:  Jacquelyn S Carr; Syed F Zafar; Nabil Saba; Fadlo R Khuri; Bassel F El-Rayes
Journal:  J Gastrointest Cancer       Date:  2013-06

4.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Authors:  B J Reid; L J Prevo; P C Galipeau; C A Sanchez; G Longton; D S Levine; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

5.  Predicting Neoplastic Progression in Barrett's Esophagus.

Authors:  Jean S Wang; Marcia I Canto
Journal:  Ann Gastroentol Hepatol       Date:  2010-06

Review 6.  Pathophysiology and treatment of Barrett's esophagus.

Authors:  Daniel S Oh; Steven R Demeester
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

7.  Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology.

Authors:  G J S Jenkins; S H Doak; A P Griffiths; N Tofazzal; V Shah; J N Baxter; J M Parry
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

8.  Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.

Authors:  M M Streppel; S Lata; M DelaBastide; E A Montgomery; J S Wang; M I Canto; A M Macgregor-Das; S Pai; F H M Morsink; G J Offerhaus; E Antoniou; A Maitra; W R McCombie
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

9.  DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus.

Authors:  Jean S Wang; Mingzhou Guo; Elizabeth A Montgomery; Richard E Thompson; Hilary Cosby; Lisa Hicks; Shelun Wang; James G Herman; Marcia I Canto
Journal:  Am J Gastroenterol       Date:  2009-07-07       Impact factor: 10.864

10.  Improvement of endocytoscopic findings after per oral endoscopic myotomy (POEM) in esophageal achalasia; does POEM reduce the risk of developing esophageal carcinoma? Per oral endoscopic myotomy, endocytoscopy and carcinogenesis.

Authors:  Hitomi Minami; Naoyuki Yamaguchi; Kayoko Matsushima; Yuko Akazawa; Ken Ohnita; Fuminao Takeshima; Toshiyuki Nakayama; Tomayoshi Hayashi; Haruhiro Inoue; Kazuhiko Nakao; Hajime Isomoto
Journal:  BMC Gastroenterol       Date:  2013-01-30       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.